logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Azurity Pharmaceuticals, Inc. drugs

    FiltersReset Filters
    19 results

    • azmiro

      (TESTOSTERONE CYPIONATE)
      Azurity Pharmaceuticals, Inc.
      Usage: AZMIRO is indicated for testosterone replacement therapy in males with conditions causing testosterone deficiency, including primary hypogonadism (e.g., testicular failure, Klinefelter’s syndrome) and hypogonadotropic hypogonadism (e.g., pituitary-hypothalamic injury). The safety and efficacy for age-related hypogonadism and pediatric patients under 12 are not established.

    • brynovin - sitagliptin hydrochloride oral solution

      (Sitagliptin Hydrochloride Oral)
      Azurity Pharmaceuticals, Inc.

    • danziten - nilotinib tablet

      (Nilotinib)
      Azurity Pharmaceuticals, Inc.

    • edarbi

      (Azilsartan kamedoxomil)
      Azurity Pharmaceuticals, Inc.
      Usage: Edarbi is indicated for treating hypertension in adults to lower blood pressure, thereby reducing the risk of cardiovascular events such as strokes and myocardial infarctions. It can be used alone or with other antihypertensive medications as part of comprehensive cardiovascular risk management.

    • epaned

      (enalapril maleate)
      Azurity Pharmaceuticals, Inc.
      Usage: EPANED is indicated for treating hypertension in adults and children over one month, improving cardiovascular outcomes. It is also indicated for symptomatic heart failure, often with diuretics and digitalis, enhancing survival and reducing hospitalizations, and for asymptomatic left ventricular dysfunction, decreasing progression to overt heart failure.

    • eprontia - topiramate solution

      (Topiramate)
      Azurity Pharmaceuticals, Inc.

    • evekeo - amphetamine sulfate tablet

      (Amphetamine Sulfate)
      Azurity Pharmaceuticals, Inc.

    • fleqsuvy

      (baclofen)
      Azurity Pharmaceuticals, Inc.
      Usage: FLEQSUVY is indicated for treating spasticity due to multiple sclerosis, relieving flexor spasms, pain, clonus, and muscular rigidity. It may also benefit patients with spinal cord injuries or diseases, but is not intended for skeletal muscle spasms from rheumatic disorders.

    • katerzia

      (Amlodipine)
      Azurity Pharmaceuticals, Inc.
      Usage: KATERZIA is indicated for treating hypertension in adults and children (6+ years) to lower blood pressure, thus reducing cardiovascular event risks. It is also used for symptomatic treatment of chronic stable angina, vasospastic angina, and to decrease hospitalization and revascularization risk in patients with documented coronary artery disease.

    • konvomep

      (omeprazole and sodium bicarbonate)
      Azurity Pharmaceuticals, Inc.
      Usage: KONVOMEP is indicated for short-term treatment (4 to 8 weeks) of active benign gastric ulcers and for reducing the risk of upper gastrointestinal bleeding in critically ill adult patients.